keyword
MENU ▼
Read by QxMD icon Read
search

lamictal withdrawal

keyword
https://www.readbyqxmd.com/read/26598477/adjunctive-maintenance-lamotrigine-for-pediatric-bipolar-i-disorder-a-placebo-controlled-randomized-withdrawal-study
#1
RANDOMIZED CONTROLLED TRIAL
Robert L Findling, Kiki Chang, Adelaide Robb, Vicki J Foster, Joseph Horrigan, Alok Krishen, Art Wamil, John E Kraus, Melissa DelBello
OBJECTIVE: This study aimed to compare the efficacy of lamotrigine versus placebo in 10- to 17-year-olds with bipolar I disorder (BP-I) who were receiving conventional bipolar disorder treatment. METHOD: In this randomized withdrawal trial, patients with BP-I of at least moderate severity received lamotrigine during an ≤18-week open-label phase. Patients who maintained a stable lamotrigine dose for ≥2 weeks and Clinical Global Impression-Bipolar Severity of Illness (CGI-BP[S]) score of ≤3 for ≥6 consecutive weeks were randomized to double-blind lamotrigine or placebo for ≤36 weeks...
December 2015: Journal of the American Academy of Child and Adolescent Psychiatry
https://www.readbyqxmd.com/read/10563619/a-placebo-controlled-trial-of-lamotrigine-add-on-therapy-for-partial-seizures-in-children-lamictal-pediatric-partial-seizure-study-group
#2
RANDOMIZED CONTROLLED TRIAL
M Duchowny, J M Pellock, W D Graf, C Billard, J Gilman, E Casale, G Womble, M Risner, P Manasco
OBJECTIVE: To compare the safety and efficacy of add-on lamotrigine and placebo in the treatment of children and adolescents with partial seizures. BACKGROUND: Add-on and monotherapy lamotrigine is safe and effective in adults with partial seizures, and reports of preliminary uncontrolled trials suggest similar benefits in children. METHODS: We studied 201 children with diagnoses of partial seizures of any subtype currently receiving stable conventional regimens of antiepileptic therapy at 40 study sites in the United States and France...
November 10, 1999: Neurology
https://www.readbyqxmd.com/read/2612495/double-blind-crossover-trial-of-lamotrigine-lamictal-as-add-on-therapy-in-intractable-epilepsy
#3
C D Binnie, R M Debets, M Engelsman, J W Meijer, H Meinardi, J Overweg, A W Peck, A Van Wieringen, W C Yuen
A double-blind, placebo-controlled trial is reported of lamotrigine as add-on treatment in therapy-resistant epilepsy. A within-patients serial design was used, with two 3-month treatment periods and an intervening 6-week washout/crossover period. An unblinded investigator adjusted lamotrigine dosage to achieve a plasma concentration within a previously predicted therapeutic range. All patients had therapy-resistant partial seizures, some in combination with other seizure types and were without serious neurological or intellectual deficit...
November 1989: Epilepsy Research
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"